MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$8,277,850
Loss before income
taxes
-$8,277,850
Loss from operations
-$4,163,691
Change in fair value of
contingent consideration...
-$4,089,753
Interest expense, net
-$24,406
Total operating
expenses
$4,163,691
General and
administrative
$3,315,433
Research and development
$445,512
Asset impairment loss
$402,746
Back
Back
Income Statement
source: myfinsight.com
Hepion Pharmaceuticals, Inc. (CTRVP)
Hepion Pharmaceuticals, Inc. (CTRVP)